Ovarian preservation and staging in reproductive-age endometrial cancer patients

Gynecologic Oncology

Volumn 114, Issue 1, 2009, Pages 99-104

  Richter, Christine E ^a   Qian, Biyun ^b   Martel, Maritza ^a   Yu, Herbert ^b   Azodi, Masoud ^a   Rutherford, Thomas J ^a   Schwartz, Peter E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Bilateral salpingo oophorectomy; Endometrial cancer; Outcome; Ovarian preservation; Reproductive age women; Surgical and clinical staging

Indexed keywords

DOXORUBICIN; PACLITAXEL; PLATINUM DERIVATIVE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER STAGING; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; SURVIVAL TIME;

ADULT; CORONARY DISEASE; DIABETES COMPLICATIONS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FALLOPIAN TUBES; FEMALE; FERTILITY; FUNCTIONAL LATERALITY; HUMANS; HYPERTENSION; MIDDLE AGED; NEOPLASM STAGING; OVARIECTOMY; OVARY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS;

EID: 67349203966     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.032     Document Type: Article

References (27)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J. Clin. 58 2 (2008) 71-96
2. Pellerin G.P., and Finan M.A. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am. J. Obstet. Gynecol. 193 5 (2005) 1640-1644
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 57 1 (2007) 43-66
4. Brémond A., Bataillard A., Thomas L., Archard J.L., Fervers B., Fondrinier E., et al. Fédération National des Centres de Lutte Contre le Cancer. Gynecol. Obstet. Fertil. 30 11 (2002) 902-916
5. Creasman W.T. New gynecologic cancer staging. Obstet. Gynecol. 75 2 (1990) 287-288
6. Burke C., and Hickey K. Does surgical staging of clinical stage I endometrial carcinoma significantly alter adjuvant management?. J. Obstet. Gynecol. 24 3 (2004) 289-291
7. Gotlieb W.H., Beiner M.E., Shalmon B., Korach Y., Segal Y., Zmira N., et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet. Gynecol. 102 4 (2003) 718-725
8. Orshan S.A., Furniss K.K., Forst C., and Santoro N. The lived experience of premature ovarian failure. J. Obstet. Gynecol. Neonatal Nurs. 30 2 (2001) 202-208
9. Lee T.S., Jung J.Y., Kim J.W., Park N.H., Song Y.S., Kang S.B., et al. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol. Oncol. 104 1 (2007) 52-57
10. Walsh C., Holschneider C., Hoang Y., Tieu K., Karlan B., and Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet. Gynecol. 106 4 (2005) 693-699
11. Slomovitz B.M., Burke T.W., Eifel P.J., Ramondetta L.M., Silva E.G., Jhingran A., et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol. Oncol. 91 3 (2003) 463-469
12. Hamilton C.A., Cheung M.K., Osann K., Chen L., Teng N.N., Longacre T.A., et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br. J. Cancer 94 (2006) 642-646
13. Evans-Metcalf E.R., Brooks S.E., Reale F.R., and Baker S.P. Profile of women 45 years of age and younger with endometrial cancer. Obstet. Gynecol. 91 3 (1998) 349-354
14. Rackow B.W., and Arici A. Endometrial cancer and fertility. Curr. Opin. Obstet. Gynecol. 18 3 (2006) 245-252
15. Shuster L.T., Gostout B.S., Grossardt B.R., and Rocca W.A. Prophylactic oophorectomy in pre-menopausal women and long-term health - a review. Menopause Int. 14 3 (2008) 111-116
16. Dørum A., Tonstad S., Liavaag A.H., Michelsen T.M., Hildrum B., and Dahl A.A. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecol. Oncol. 109 3 (2008) 377-383
17. Barnes M.N., and Kilgore L.C. Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes. Semin. Radiat. Oncol. 10 1 (2000) 3-7
18. Yokoyama Y., Maruyama H., Sato S., and Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol. Oncol. 64 3 (1997) 411-417
19. Orr Jr. J.W., Roland P.Y., Leichter D., and Orr P.F. Endometrial cancer: is surgical staging necessary?. Curr. Opin. Oncol. 13 5 (2001) 408-412
20. Kilgore L.C., Partridge E.E., Alvarez R.D., Austin J.M., Shingleton H.M., Noojin III F., et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56 1 (1995) 29-33
21. Zuurendonk L.D., Smit R.A., Mol B.W., Feijen H.W., de Graaff J., Sykora D., et al. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. Eur. J. Surg. Oncol. 32 4 (2006) 450-454
22. COSA-NZ-UK. Endometrial Cancer Study Groups. Pelvic lymphadenectomy in high risk endometrial cancer. Int. J. Cancer 6 (1996) 102-107
23. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group Study. Gynecol. Oncol. 40 1 (1991) 55-65
24. Petersen R.W., Quinlivan J.A., Casper G.R., and Nicklin J.L. Endometrial adenocarcinoma - presenting pathology is a poor guide to surgical management. Aust. N. Z. J. Obstet. Gynaecol. 40 2 (2000) 191-194
25. Frumovitz M., Singh D.K., Meyer L., Smith D.H., Wertheim I., Resnik E., et al. Predictors of final histology in patients with endometrial cancer. Gynecol. Oncol. 95 3 (2004) 463-468
26. Frumovitz M., Slomovitz B.M., Singh D.K., Broaddus R.R., Abrams J., Sun C.C., et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J. Am. Surg. 199 3 (2004) 388-393
27. Barakat R.R., Bundy B.N., Spirtos N.M., Bell J., and Mannel R.S. Gynecologic Oncology Group Study. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 24 4 (2006) 587-592